Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
BIOLIFE SOLUTIONS INC (BLFS) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/26/2023 SC 13G INTEGRATED CORE STRATEGIES LLC reports a 5.7% stake in BIOLIFE SOLUTIONS, INC.
08/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: " "
08/16/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "BioLife Solutions Reports Second Quarter 2023 Financial Results, Updates Full Year 2023 Guidance and Provides Pro Forma First Half 2023 Financial Profile Excluding Freezer Business"
07/27/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/06/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
06/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/19/2023 8-K Shareholder Nominations Pursuant to Exchange Act Rule 14a-11  Interactive Data
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/10/2023 8-K Quarterly results
Docs: " "
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/23/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
03/17/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
03/16/2023 8-K Quarterly results
Docs: " "
01/20/2023 SC 13G/A BlackRock Inc. reports a 12.8% stake in BIOLIFE SOLUTIONS INC
01/11/2023 SC 13G/A MILLENNIUM MANAGEMENT LLC reports a 1.6% stake in BIOLIFE SOLUTIONS, INC.
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/09/2022 8-K Quarterly results
10/06/2022 8-K Quarterly results
09/26/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
09/12/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/26/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "BioLife Solutions Appoints Cell Therapy Executive Timothy L. Moore to its Board of Directors"
08/09/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/09/2022 8-K Quarterly results
Docs: " "
07/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/22/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/15/2022 8-K Quarterly results
05/10/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/09/2022 8-K Quarterly results
04/29/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/07/2022 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
Docs: " "
03/18/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
Docs: " "
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy